|
1
|
Ferlay J, Randi G, Bosetti C, Levi F,
Negri E, Boyle P and Vecchia CL: Declining mortality from bladder
cancer in Europe. BJU Int. 101:11–9. 2008.PubMed/NCBI
|
|
2
|
Eble JN, Sauter G, Epstein JI and
Sesterhenn IA: Pathology and genetics of tumours of the urinary
system and male genital organsWorld Health Organization
Classification of Tumors. IARC Press; Lyon: pp. 90–126. 2004
|
|
3
|
Gonzalez-Campora R, Davalos-Casanova G,
Beato-Moreno A, Luque RJ, Alvarez-Kindelan J, Requena MJ, Montironi
R and Lopez-Beltrán A: Apoptotic and proliferation indexes in
primary superficial bladder tumors. Cancer Lett. 242:266–272. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Desai S, Lim SD, Jimenez RE, Chun T, Keane
TE, McKenney JK, Zavala-Pompa A, Cohen C, Young RH and Amin MB:
Relationship of cytokeratin 20 and CD44 protein expression with
WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia. Mod
Pathol. 13:1315–1323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bertz S, Otto W, Denzinger S, Wieland WF,
Burger M, Stöhr R, Link S, Hofstädter F and Hartmann A: Combination
of CK20 and Ki-67 immunostaining analysis predicts recurrence,
progression and cancer-Specific survival in pT1 urothelial bladder
cancer. Eur Urol. 65:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Southgate J, Harnden P and Trejdosiewicz
LK: Cytokeratin expression patterns in normal and malignant
urothelium: a review of the biological and diagnostic implications.
Histol Histopathol. 14:657–664. 1999.PubMed/NCBI
|
|
7
|
Van Oers JM, Wild PJ, Burger M, Denzinger
S, Stoehr R, Rosskopf E, Hofstaedter F, Steyerberg EW,
Klinkhammer-Schalke M, Zwarthoff EC, et al: FGFR3 mutations and a
normal CK20 staining pattern define low-grade noninvasive
urothelial bladder tumours. Eur Urol. 52:760–768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lei M and Tye BK: Initiating DNA
synthesis: from recruiting to activating the MCM complex. J Cell
Sci. 114:1447–1454. 2001.PubMed/NCBI
|
|
9
|
Koonin EV: A common set of conserved
motifs in a vast variety of putative nucleic acid-dependent ATPases
including MCM proteins involved in the initiation of eukaryotic DNA
replication. Nucleic Acids Res. 21:2541–2547. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dimitrova DS, Prokhorova TA, Blow JJ,
Todorov IT and Gilbert DM: Mammalian nuclei become licensed for DNA
replication during late telophase. J Cell Sci. 115:51–59.
2002.PubMed/NCBI
|
|
11
|
Shohet JM, Hicks MJ, Plon SE, Burlingame
SM, Stuart S, Chen SY, Brenner MK and Nuchtern JG: Minichromosome
maintenance protein MCM7 Is a direct target of the MYCN
transcription factor in neuroblastoma. Cancer Res. 62:1123–1128.
2002.PubMed/NCBI
|
|
12
|
Fitch MJ, Donato JJ and Tye BK: Mcm7, a
subunit of the presumptive MCM helicase, modulates its own
expression in conjunction with Mcm1. J Biol Chem. 278:25408–25416.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cortez D, Glick G and Elledge SJ:
Minichromosome maintenance proteins are direct targets of the ATM
and ATR checkpoint kinases. Proc Natl Acad Sci USA.
101:10078–10083. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kimura F, Okayasu I, Kakinuma H, Satoh Y,
Kuwao S, Saegusa M and Watanabe J: Differential diagnosis of
reactive mesothelial cells and malignant mesothelioma cells using
the cell proliferation markers minichromosome maintenance protein
7, geminin, topoisomerase II alpha and Ki-67. Acta Cytol.
57:384–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ren B, Yu G, Tseng GC, Cieply K, Gavel T,
Nelson J, Michalopoulos G, Yu YP and Luo JH: MCM7 amplification and
overexpression are associated with prostate cancer progression.
Oncogene. 25:1090–1098. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bakkar AA, Wallerand H, Radvanyi F, et al:
FGFR3 and TP53 gene mutations define two distinct pathways in
urothelial cell carcinoma of the bladder. Cancer Res. 63:8108–8112.
2003.PubMed/NCBI
|
|
17
|
van Rhijn BW, Vis AN, van der Kwast TH, et
al: Molecular grading of urothelial cell carcinoma with fibroblast
growth factor receptor 3 and MIB-1 is superior to pathologic grade
for the prediction of clinical outcome. J Clin Oncol. 21:1912–1921.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Oh IJ, Kim HE, Song SY, et al: Diagnostic
value of serum glutathione peroxidase 3 levels in patients with
lung cancer. Thoracic Cancer. 5:425–430. 2014. View Article : Google Scholar
|
|
19
|
Liu YT, Shi YK, Hao XZ, et al: Analysis of
clinicopathological features of the echinoderm
microtubule-associated protein-like-4-anaplastic lymphoma kinase
fusion gene in Chinese patients with advanced non-small-cell lung
cancer. Thoracic Cancer. 5:255–260. 2014. View Article : Google Scholar
|
|
20
|
Üstündag S and Zencirci AD: Factors
affecting the quality of life of cancer patients undergoing
chemotherapy: A questionnaire study. Asia-Pacific J Oncol Nurs.
2:17–25. 2015. View Article : Google Scholar
|
